Physician profile
Eric D Freeman
NPI 1184720930
$3,491.14
in general payments reported to CMS, 2019-2025
16 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $523 · 2021: $219 · 2022: $172 · 2023: $318 · 2024: $785 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,544.45 | 2019-2023 | Senza |
| Boston Scientific Corporation | $772.42 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Epimed International, INC | $325.19 | 2024 | Prp |
| Medtronic, INC. | $269.12 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Nuvasive, INC. | $157.09 | 2020 | |
| Si-Bone, INC. | $95.75 | 2020 | |
| Vertos Medical, INC. | $81.28 | 2019-2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $66.68 | 2021 | |
| Nalu Medical, INC. | $58.30 | 2021-2023 | Nalu Neurostimulation System |
| Daiichi Sankyo INC. | $21.72 | 2019 | |
| Saluda Medical Americas, INC. | $20.10 | 2023 | Evoke Scs |
| Collegium Pharmaceutical, INC. | $17.12 | 2024 | Belbuca |
| Janssen Pharmaceuticals, INC | $16.66 | 2022 | |
| Averitas Pharma INC. | $15.76 | 2023 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.69 | 2023 | Relistor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.81 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.